News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pharmatek Laboratories, Inc. Announces New Seminar Series Pharmatek University Aims to Enhance Drug Development Knowledge in San Diego


12/5/2007 9:42:00 AM

SAN DIEGO, Dec. 5 /PRNewswire/ -- Pharmatek Laboratories, Inc. today announced the launch of Pharmatek University (Pharmatek U(TM)), a continuing education program for drug development scientists.

Pharmatek University is designed to provide a forum of scientific exchange for the local biotechnology and pharmaceutical industry. Topics focus on drug development and pharmaceutical technology. Seminars will cover issues such as analytical chemistry, formulation development, GMP manufacturing, toxicology, PK/ADME, drug safety, design of clinical trials, regulatory affairs, and drug delivery and pharmaceutical technology.

"Pharmatek U has always been a part of our corporate culture, a sort of continuing education program for Pharmatek scientists," said Timothy Scott, president of Pharmatek. "The Pharmatek U Seminar Series represents a forum that all of us in the broader San Diego pharma community can participate in - a way of educating ourselves on a wide range of drug development topics and best practices. The program is designed to enhance scientists' understanding of drug development, allowing them to move drug candidates through the clinic faster and more effectively."

Seminars are held from 8:00 a.m. to 9:00 a.m. at Pharmatek Laboratories located at 7330 Carroll Road, San Diego, California 92121. Sessions are open to all interested in drug development at no cost. For information and to register, visit www.pharmatek.com/PTEKU.html or contact Elizabeth Hickman at (858) 805-6383.

The first seminar in this series is scheduled for Thursday, December 6, 2007. Robert Ternansky, Ph.D., former senior vice president, chemistry for Attenuon, LLC, will present "Selecting and Managing a Contract Research Organization."

Future speakers include Judy Senior of Senior Consulting who will present on the topic of parenteral drug delivery and Jeff Schwegman of BioConvergence who will present on the topic of protein drug development.

About Pharmatek Laboratories, Inc.

Pharmatek Laboratories Inc. is a premier pharmaceutical chemistry development company providing full-service pharmaceutical chemistry product development for the pharmaceutical industry. Pharmatek focuses on bringing client compounds from discovery to the clinic with services that include compound selection, analytical development, preformulation testing, formulation development, GMP manufacturing, stability storage and testing, and cytotoxic and high-potency development.

Statements contained in this media release which are not historical facts may constitute forward-looking statements. All forward-looking statements are subject to risks and uncertainties which could cause actual results to differ from those projected including sales forecasts and strategic expansion. The trademarks Pharmatek, Pharmatek Laboratories, Inc., Hot Rod Chemistry, Pharmatek Formulation Screening, Pharmatek University and PTEK U are all property of Pharmatek Laboratories, Inc. Additional information about Pharmatek Laboratories may be obtained at the Web site http://www.pharmatek.com or by calling 858-805-6383.

ehickman@pharmatek.com

CONTACT: Elizabeth Hickman, Marketing Manager of Pharmatek Laboratories,
Inc., +1-858-805-6383, ehickman@pharmatek.com

Web site: http://www.pharmatek.com//


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES